Latent TB infection treatment acceptance and completion in the United States and Canada CR Horsburgh Jr, S Goldberg, J Bethel, S Chen, PW Colson, ... Chest 137 (2), 401-409, 2010 | 296 | 2010 |
Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada Y Hirsch-Moverman, A Daftary, J Franks, PW Colson The international journal of tuberculosis and lung disease 12 (11), 1235-1254, 2008 | 270 | 2008 |
Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States SE Dorman, R Belknap, EA Graviss, R Reves, N Schluger, P Weinfurter, ... American journal of respiratory and critical care medicine 189 (1), 77-87, 2014 | 264 | 2014 |
Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007 SM Marks, J Flood, B Seaworth, Y Hirsch-Moverman, L Armstrong, ... Emerging infectious diseases 20 (5), 812, 2014 | 242 | 2014 |
Child contact management in high tuberculosis burden countries: a mixed-methods systematic review D Szkwarko, Y Hirsch-Moverman, L Du Plessis, K Du Preez, C Carr, ... PloS one 12 (8), e0182185, 2017 | 115 | 2017 |
Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study J Franks, Y Hirsch-Moverman, AS Loquere, KR Amico, RM Grant, BJ Dye, ... AIDS and Behavior 22, 1139-1149, 2018 | 100 | 2018 |
Using mHealth for HIV/TB treatment support in Lesotho: enhancing patient–provider communication in the START study Y Hirsch-Moverman, A Daftary, KA Yuengling, S Saito, M Ntoane, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74, S37-S43, 2017 | 97 | 2017 |
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV MR O'Donnell, A Daftary, M Frick, Y Hirsch-Moverman, KR Amico, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 430-434, 2016 | 96 | 2016 |
Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city M Garnett, Y Hirsch-Moverman, J Franks, E Hayes-Larson, WM El-Sadr, ... AIDS care 30 (1), 9-17, 2018 | 92 | 2018 |
Latent tuberculous infection in the United States and Canada: who completes treatment and why? Y Hirsch-Moverman, R Shrestha-Kuwahara, J Bethel, HM Blumberg, ... The International Journal of Tuberculosis and Lung Disease 19 (1), 31-38, 2015 | 66 | 2015 |
Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience Y Hirsch-Moverman, J Bethel, PW Colson, J Franks, W El-Sadr The International journal of tuberculosis and lung disease 14 (9), 1104-1111, 2010 | 66 | 2010 |
Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada PW Colson, Y Hirsch-Moverman, J Bethel, P Vempaty, K Salcedo, K Wall, ... The International journal of tuberculosis and lung disease 17 (4), 473-479, 2013 | 57 | 2013 |
Daily and nondaily oral preexposure prophylaxis in men and transgender women who have sex with men: the human immunodeficiency virus prevention trials network 067/ADAPT study RM Grant, S Mannheimer, JP Hughes, Y Hirsch-Moverman, A Loquere, ... Clinical Infectious Diseases 66 (11), 1712-1721, 2018 | 56 | 2018 |
Tuberculosis knowledge, attitudes, and beliefs in foreign-born and US-born patients with latent tuberculosis infection PW Colson, J Franks, R Sondengam, Y Hirsch-Moverman, W El-Sadr Journal of Immigrant and Minority Health 12, 859-866, 2010 | 55 | 2010 |
Risk factors for tuberculosis and effect of preventive therapy among close contacts of persons with infectious tuberculosis MR Reichler, A Khan, TR Sterling, H Zhao, B Chen, Y Yuan, J Moran, ... Clinical Infectious Diseases 70 (8), 1562-1572, 2020 | 43 | 2020 |
Risk factors for treatment default in close contacts with latent tuberculous infection CT Fiske, FX Yan, Y Hirsch-Moverman, TR Sterling, MR Reichler The International Journal of Tuberculosis and Lung Disease 18 (4), 421-427, 2014 | 40 | 2014 |
Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection? Y Hirsch-Moverman, PW Colson, J Bethel, J Franks, WM El-Sadr The international journal of tuberculosis and lung disease 17 (9), 1178-1185, 2013 | 37 | 2013 |
Response rates of medical providers to internet surveys regarding their adoption of preexposure prophylaxis for HIV: methodological implications TB Silverman, EW Schrimshaw, J Franks, Y Hirsch-Moverman, H Ortega, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2018 | 34 | 2018 |
Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005–2007 SM Marks, Y Hirsch-Moverman, K Salcedo, EA Graviss, P Oh, B Seaworth, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 435-441, 2016 | 34 | 2016 |
Adherence to pre-exposure prophylaxis in black men who have sex with men and transgender women in a community setting in Harlem, NY PW Colson, J Franks, Y Wu, FS Winterhalter, J Knox, H Ortega, ... AIDS and Behavior 24, 3436-3455, 2020 | 32 | 2020 |